208 related articles for article (PubMed ID: 25686852)
1. Synthesis and biological evaluation of novel pyrrolidine acid analogs as potent dual PPARα/γ agonists.
Zhang H; Ding CZ; Lai Z; Chen SS; Devasthale P; Herpin T; Morton G; Qu F; Ryono D; Smirk R; Wang W; Wu S; Ye XX; Li YX; Apedo A; Farrelly D; Wang T; Gu L; Morgan N; Flynn N; Chu C; Kunselman L; Lippy J; Locke K; O'Malley K; Harrity T; Cap M; Zhang L; Hosagrahara V; Kadiyala P; Xu C; Doweyko AM; Zahler R; Hariharan N; Cheng PT
Bioorg Med Chem Lett; 2015 Mar; 25(6):1196-205. PubMed ID: 25686852
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Structure-Activity Relationships of 2-Aminoacetamide Derivatives as Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists.
Shibata Y; Kagechika K; Ota M; Yamaguchi M; Setoguchi M; Kubo H; Chiba K; Takano H; Akiyama C; Ono M; Nishi M; Usui H
Chem Pharm Bull (Tokyo); 2015; 63(8):591-602. PubMed ID: 26235167
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonists.
Zhang H; Ryono DE; Devasthale P; Wang W; O'Malley K; Farrelly D; Gu L; Harrity T; Cap M; Chu C; Locke K; Zhang L; Lippy J; Kunselman L; Morgan N; Flynn N; Moore L; Hosagrahara V; Zhang L; Kadiyala P; Xu C; Doweyko AM; Bell A; Chang C; Muckelbauer J; Zahler R; Hariharan N; Cheng PT
Bioorg Med Chem Lett; 2009 Mar; 19(5):1451-6. PubMed ID: 19201606
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia.
Liu K; Xu L; Berger JP; Macnaul KL; Zhou G; Doebber TW; Forrest MJ; Moller DE; Jones AB
J Med Chem; 2005 Apr; 48(7):2262-5. PubMed ID: 15801817
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of novel zwitterionic compounds as PPARα/γ dual agonists (1).
Shibata Y; Kagechika K; Yamaguchi M; Kubo H; Usui H
Bioorg Med Chem Lett; 2012 Dec; 22(23):7075-9. PubMed ID: 23084275
[TBL] [Abstract][Full Text] [Related]
6. Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
Humphries PS; Almaden JV; Barnum SJ; Carlson TJ; Do QQ; Fraser JD; Hess M; Kim YH; Ogilvie KM; Sun S
Bioorg Med Chem Lett; 2006 Dec; 16(23):6116-9. PubMed ID: 16979341
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of novel zwitterionic compounds as peroxisome proliferator activated receptor α/γ dual agonists with improved physicochemical properties.
Shibata Y; Kagechika K; Yamaguchi M; Yoshikawa K; Chiba K; Takano H; Akiyama C; Ono M; Nishi M; Kubo H; Kobayashi Y; Usui H
Chem Pharm Bull (Tokyo); 2013; 61(12):1248-63. PubMed ID: 24292787
[TBL] [Abstract][Full Text] [Related]
8. Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
Humphries PS; Bailey S; Almaden JV; Barnum SJ; Carlson TJ; Christie LC; Do QQ; Fraser JD; Hess M; Kellum J; Kim YH; McClellan GA; Ogilvie KM; Simmons BH; Skalitzky D; Sun S; Wilhite D; Zehnder LR
Bioorg Med Chem Lett; 2006 Dec; 16(23):6120-3. PubMed ID: 16973358
[TBL] [Abstract][Full Text] [Related]
9. PPAR dual agonists: are they opening Pandora's Box?
Balakumar P; Rose M; Ganti SS; Krishan P; Singh M
Pharmacol Res; 2007 Aug; 56(2):91-8. PubMed ID: 17428674
[TBL] [Abstract][Full Text] [Related]
10. [Design, synthesis, and PPARalpha/gamma agonistic activity of novel tetrahydroisoquinoline derivatives].
Yu R; Zhou YL; Huan Y; Liu Q; Shen ZF; Liu ZZ
Yao Xue Xue Bao; 2011 Mar; 46(3):311-6. PubMed ID: 21626786
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.
Devasthale PV; Chen S; Jeon Y; Qu F; Shao C; Wang W; Zhang H; Cap M; Farrelly D; Golla R; Grover G; Harrity T; Ma Z; Moore L; Ren J; Seethala R; Cheng L; Sleph P; Sun W; Tieman A; Wetterau JR; Doweyko A; Chandrasena G; Chang SY; Humphreys WG; Sasseville VG; Biller SA; Ryono DE; Selan F; Hariharan N; Cheng PT
J Med Chem; 2005 Mar; 48(6):2248-50. PubMed ID: 15771468
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of oxime ethers of alpha-acyl-beta-phenylpropanoic acids as PPAR dual agonists.
Oon Han H; Kim SH; Kim KH; Hur GC; Joo Yim H; Chung HK; Ho Woo S; Dong Koo K; Lee CS; Sung Koh J; Kim GT
Bioorg Med Chem Lett; 2007 Feb; 17(4):937-41. PubMed ID: 17157019
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of carbazole derivatives as PPAR alpha/gamma dual agonists and antioxidants.
Kumar R; Ramachandran U; Srinivasan K; Ramarao P; Raichur S; Chakrabarti R
Bioorg Med Chem; 2005 Jul; 13(13):4279-90. PubMed ID: 15869880
[TBL] [Abstract][Full Text] [Related]
14. Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists.
Grether U; Bénardeau A; Benz J; Binggeli A; Blum D; Hilpert H; Kuhn B; Märki HP; Meyer M; Mohr P; Püntener K; Raab S; Ruf A; Schlatter D
ChemMedChem; 2009 Jun; 4(6):951-6. PubMed ID: 19326383
[TBL] [Abstract][Full Text] [Related]
15. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
16. Discovery of azetidinone acids as conformationally-constrained dual PPARalpha/gamma agonists.
Wang W; Devasthale P; Farrelly D; Gu L; Harrity T; Cap M; Chu C; Kunselman L; Morgan N; Ponticiello R; Zebo R; Zhang L; Locke K; Lippy J; O'Malley K; Hosagrahara V; Zhang L; Kadiyala P; Chang C; Muckelbauer J; Doweyko AM; Zahler R; Ryono D; Hariharan N; Cheng PT
Bioorg Med Chem Lett; 2008 Mar; 18(6):1939-44. PubMed ID: 18291645
[TBL] [Abstract][Full Text] [Related]
17. Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I.
Devasthale PV; Chen S; Jeon Y; Qu F; Ryono DE; Wang W; Zhang H; Cheng L; Farrelly D; Golla R; Grover G; Ma Z; Moore L; Seethala R; Sun W; Doweyko AM; Chandrasena G; Sleph P; Hariharan N; Cheng PT
Bioorg Med Chem Lett; 2007 Apr; 17(8):2312-6. PubMed ID: 17292606
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
Han KL; Choi JS; Lee JY; Song J; Joe MK; Jung MH; Hwang JK
Diabetes; 2008 Mar; 57(3):737-45. PubMed ID: 18065517
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists.
Suh YG; Kim NJ; Koo BW; Lee KO; Moon SH; Shin DH; Jung JW; Paek SM; Chang DJ; Li F; Kang HJ; Le TV; Chae YN; Shin CY; Kim MK; Lim JI; Ryu JS; Park HJ
J Med Chem; 2008 Oct; 51(20):6318-33. PubMed ID: 18826205
[TBL] [Abstract][Full Text] [Related]
20. Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice.
Park MH; Park JY; Lee HJ; Kim DH; Park D; Jeong HO; Park CH; Chun P; Moon HR; Chung HY
PLoS One; 2013; 8(11):e78815. PubMed ID: 24244369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
